Tetrasiklin ve Sulfonamid Direnç Mekanizmaları

Roberts MC. Tetracycline therapy: update. Clinical Infectious Diseases. 2003;36:462-467. doi: 10.1086/367622

Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiology and Molecular Biology Reviews. 2001;65:232-260. doi: 10.1128/MMBR.65.2.232-260.2001

Thaker M, Spanogiannopoulos P, Wright GD. The tetracycline resistome. Cellular and Molecular Life Sciences. 2010;67:419-431. doi: 10.1007/s00018-009-0172-6

Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clinical Therapeitics. 2005;27:1329-1342. doi: 10.1016/j.clinthera.2005.09.005

Lebrun-Vignes B, Kreft-Jais C, Castot A, et al. Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. The British Journal of Dermatology. 2012;166:1333-1341. doi: 10.1111/j.1365-2133.2012.10845.x

Fanning WL, Gump DW, Sofferman RA. Side effects of minocycline: a double-blind study. Antimicrobial Agents and Chemotherapy. 1977;11:712-717. doi: 10.1128/aac.11.4.712

Carney S, Butcher RA, Dawborn JK, et al. Minocycline excretion and distribution in relation to renal function in man. Clinical and Experimental Pharmacology and Physiology. 1974;1:299-308. doi: 10.1111/j.1440-1681.1974.tb00552.x

Speer BS, Bedzyk L, Salyers AA. Evidence that a novel tetracycline resistance gene found on two Bacteroides transposons encodes an NADP-requiring oxidoreductase. Journal of Bacteriology.1991;173:176-183 doi: 10.1128/jb.173.1.176-183.1991

Moore IF, Hughes DW, Wright GD. Tigecycline is modified by the flavin-dependent monooxygenase TetX. Biochemistry 2005;44: 11829-11835 doi: 10.1021/bi0506066

Diaz-Torres ML, McNab R, Spratt DA, Villedieu A, Hunt N, Wilson M, Mullany P. 2003. Novel tetracycline resistance determinant from the oral metagenome. Antimicrobial Agents and Chemotherapy.2003;47:1430-1432. doi: 10.1128/AAC.47.4.1430-1432.

Bialek-Davenet S, Lavigne JP, Guyot K, Mayer N, Tournebize R, Brisse S, Leflon-Guibout V, Nicolas-Chanoine MH. Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy.2015;70:81-88. doi: 10.1093/jac/dku340

Hornsey M, Ellington MJ, Doumith M, Scott G, Livermore DM, Woodford N. Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment. International Journal of Antimicrobial Agents 2010;35:478-481. doi: 10.1016/j.ijantimicag.2010.01.011

Keeney D, Ruzin A, Bradford PA. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microbial Drug Resistance.2007;13:1-6. doi: 10.1089/mdr.2006.9990

Trieber CA, Taylor DE. Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. Journal of Bacteriology.2002;184:2131-2140. doi: 10.1128/JB.184.8.2131-2140.2002

Brodersen DE, Clemons WM Jr, Carter AP, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V.The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell.2000;103: 1143-1154. doi: 10.1016/s0092-8674(00)00216-6

Skold O. Sulfonamide resistance: mechanisms and trends. Drug Resistance Updates 2000;3:155-160. doi: 10.1054/drup.2000.0146

Huovinen P, Sundstro¨m L, Swedberg G, Sko¨ld O. Trimethoprim and sulfonamide resistance. Antimicrobial Agents and Microbiology. 1995; 39:279-289. doi: 10.1128/aac.39.2.279

Bushby SRM, Hitchings GH. Trimethoprim, a sulphonamide potentiator. British Journal of Pharmacology 1968; 33:72-90. doi: 10.1111/j.1476-5381.1968.tb00475.x

Kohler T, Kok M, Michea-Hamzehpour M, et al. Multidrug efflux in intrincid resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy.1996;40:2288-2290. doi: 10.1128/aac.40.10.2288

Maseda H, Yoneyama H, Nakae T. Assignment of the substrate-selective subunits of the MexEI-OprN multidrug efflux pump of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy.2000; 44:658-664. doi: 10.1128/aac.44.3.658-664.2000

Huovinen P. Trimethoprim resistance. Antimicrobial Agents and Chemotherapy.1987;31:1451-1456. doi: 10.1128/aac.31.10.1451

Dale GE, Broger C, D’Arcy A, et al. A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance. Journal of Molecular Biology. 1997; 266:23-30. doi: 10.1006/jmbi.1996.0770

Pikis A, Donkersloot JA, Rodriquez WJ, Keith JM. A conservative amino acid mutation in the chromosome-encoded dihydrofolate reductase confers trimethoprim resistance in Streptococcus pneumoniae. Journal of Infectious Diseases. 1998; 178:700-706. doi: 10.1086/515371

R de Groot R, Sluijter M, de Bruyn A, et al. Genetic characterization of trimethoprim resistance in Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 1996; 40:2131-2136. doi: 10.1128/aac.40.9.2131

Adrian PV, du Plessis M, Klugman KP, Amyes SG. New trimethoprimresistant dihydrofolate reductase cassette, dhfrXV, inserted in a class 1 integron. Antimicrobial Agents and Chemotherapy.1998;42:21-24. doi: 10.1128/aac.42.9.2221

Charpentier E, Courvalin P. Emergence of the trimethoprim resistance gene dfrD in Listeria monocytogenes. Antimicrobial Agents and Chemotherapy.1997;41:1134-1136. doi: 10.1128/aac.41.5.1134

Padayachee T, Klugman KP. Novel expansions of the gene encoding dihydropteroate synthase in trimethoprim-sulfamethoxazole-resistant Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy.1999;43:2225-2230 doi: 10.1128/aac.43.9.2225

Swedberg G, Ringertz S, Skold O. Sulfonamide resistance in Streptococcus pyogenes is associated with differences in the amino acid sequence of its chromosomal dihydropteroate synthase. 1998; Antimicrobial Agents and Chemotherapy. 42:1062-1067 doi: 10.1128/aac.42.5.1062

Akiba T, Koyama K, Ishiki Y, Kimura S, Fukushima T. On the mechanism of the development of multiple-drug–resistant clones of Shigella. Japanese Journal of Microbiology 1960; 4:219-227. doi: 10.1111/j.1348-0421.1960.tb00170.x